Simultaneous Identification of Cell of Origin, Translocations, and Hotspot Mutations in Diffuse Large B-Cell Lymphoma Using a Single RNA-Sequencing Assay.

Objectives: Diffuse large B-cell lymphoma (DLBCL) is an aggressive non-Hodgkin lymphoma with a heterogenous genetic landscape that can require multiple assays to characterize. We reviewed a 1-step RNA-based assay to determine cell of origin (COO), detect translocations, and identify mutations and to...

Descripción completa

Detalles Bibliográficos
Publicado en:American Journal of Clinical Pathology Vol. 155; no. 5; pp. 748 - 755
Autores principales: Crotty, Rory, Hu, Krista, Stevenson, Kristen, Pontius, Maggie Y, Sohani, Aliyah R, Ryan, Russell J H, Rueckert, Erroll, Brauer, Heather A, Hudson, Briana, Berlin, Aaron M, Rodenbaugh, Matt, Licon, Abel, Haimes, Josh, Iafrate, A John, Nardi, Valentina, Louissaint, Abner
Formato: Journal Article
Publicado: Oxford University Press / USA May2021
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=150005078&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 150005078
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        00029173
        2RW
      jtl: American Journal of Clinical Pathology
      issn: 00029173
      maglogo: N
    pubinfo:
      dt: May2021
      vid: 155
      iid: 5
      pid: 10398
      pub: Oxford University Press / USA
    artinfo:
      ui:
        150005078
        150005078
        NLM33258912
        10.1093/ajcp/aqaa185
        NLM33258912
        150005078
      ppf: 748
      ppct: 7
      formats:
      tig:
        atl: Simultaneous Identification of Cell of Origin, Translocations, and Hotspot Mutations in Diffuse Large B-Cell Lymphoma Using a Single RNA-Sequencing Assay.
      aug:
        au:
          Crotty, Rory
          Hu, Krista
          Stevenson, Kristen
          Pontius, Maggie Y
          Sohani, Aliyah R
          Ryan, Russell J H
          Rueckert, Erroll
          Brauer, Heather A
          Hudson, Briana
          Berlin, Aaron M
          Rodenbaugh, Matt
          Licon, Abel
          Haimes, Josh
          Iafrate, A John
          Nardi, Valentina
          Louissaint, Abner
        affil: Department of Pathology, Massachusetts General Hospital , Boston
      sug:
        subj:
          Chromosome Disorders
          Lymphoma, B-Cell Pathology
          Mutation
          Lymphoma, B-Cell
          Female
          Proteins
          Middle Age
          Proteins Metabolism
          Male
          Aged, 80 and Over
          Lymphoma, B-Cell Diagnosis
          Aged
          Adult
          Middle Aged: 45-64 years
          Aged, 80 & over
          Aged: 65+ years
          Adult: 19-44 years
          Female
          Male
      ab: Objectives: Diffuse large B-cell lymphoma (DLBCL) is an aggressive non-Hodgkin lymphoma with a heterogenous genetic landscape that can require multiple assays to characterize. We reviewed a 1-step RNA-based assay to determine cell of origin (COO), detect translocations, and identify mutations and to assess the role of the assay in diagnosis.Methods: Using a single custom Archer FusionPlex Lymphoma panel, we performed anchored multiplex polymerase chain reaction-based RNA sequencing on 41 cases of de novo DLBCL. Each case was subclassified by COO, and gene fusions and hotspot mutations were identified. The findings were then compared with COO classification by the Hans immunohistochemical algorithm and NanoString technology, cytogenetics, and fluorescence in situ hybridization results.Results: Concordant COO classification by the FusionPlex panel and NanoString was observed in 35 of 41 cases (85.3%), with NanoString and Hans concordant in 33 of 41 cases (80.5%) and FusionPlex and Hans concordant in 33 of 41 cases (80.5%). The FusionPlex assay also detected 6 of 11 BCL6 translocations (4 cryptic), 2 of 3 BCL2 translocations, and 2 of 4 MYC translocations. Mutations were detected in lymphoma-related genes in 24 of 41 cases.Conclusion: This FusionPlex assay offers a single method for COO classification, mutation detection, and identification of important translocations in DLBCL. Although not replacing traditional testing, it could offer useful data when limited tissue is available.
      pubtype: Academic Journal
      doctype: Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N